SYK
Stryker Corporation Healthcare - Medical Devices Investor Relations →
Stryker Corporation (SYK) closed at $325.70 as of 2026-07-31, trading 1.0% above its 200-week moving average of $322.54. The stock is currently moving closer to the line, down from 2.6% last week. The 14-week RSI sits at 50, indicating neutral momentum.
Trading volume is running at 1.3x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.95 ratio) is neutral — neither side is clearly dominating.
Over the past 2371 weeks of data, SYK has crossed below its 200-week moving average 23 times. On average, these episodes lasted 8 weeks. Historically, investors who bought SYK at the start of these episodes saw an average one-year return of +41.8%.
With a market cap of $124.9 billion, SYK is a large-cap stock. The company generates a free cash flow yield of 4.1%. Return on equity stands at 16.5%, a solid level. The stock trades at 5.4x book value.
Over the past 33.6 years, a hypothetical investment of $100 in SYK would have grown to $9276, compared to $3098 for the S&P 500. That represents an annualized return of 14.4% vs 10.8% for the index — confirming SYK as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 28.1% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: SYK vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SYK Crosses Below the Line?
Across 16 historical episodes, buying SYK when it crossed below its 200-week moving average produced an average return of +32.7% after 12 months (median +36.0%), compared to +17.5% for the S&P 500 over the same periods. 93% of those episodes were profitable after one year. After 24 months, the average return was +60.3% vs +40.6% for the index.
Each line shows $100 invested at the moment SYK crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices SYK would reach each dislocation threshold.
Dislocation Price Levels
Prices where SYK's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $289.69 | Unusually cheap — potential buy zone |
| Value | +1σ | $306.49 | Cheap vs. own history |
| Fair Value | +0σ | $325.37 | Historical mean behavior |
| Expensive | -1σ | $346.72 | Expensive vs. own history |
| Deep Expensive | -2σ | $371.08 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from SYK's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
SYK has crossed below its 200-week MA 23 times with an average 1-year return of +41.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Aug 1981 | Aug 1981 | 2 | 1.7% | +32.2% | +252230.8% |
| Sep 1981 | Sep 1981 | 1 | 3.1% | +68.8% | +255810.2% |
| Jun 1984 | Jun 1984 | 2 | 5.4% | +66.7% | +154102.1% |
| Jul 1984 | Jul 1984 | 1 | 3.2% | +70.0% | +150246.7% |
| Oct 1984 | Oct 1984 | 4 | 2.1% | +42.8% | +144812.8% |
| Nov 1987 | Dec 1987 | 1 | 7.3% | +51.9% | +77000.9% |
| Mar 1993 | Apr 1993 | 4 | 5.2% | +32.3% | +14498.3% |
| Jun 1993 | Jun 1993 | 2 | 5.4% | +26.2% | +14419.0% |
| Nov 1993 | Dec 1993 | 1 | 8.5% | +53.2% | +13814.0% |
| Mar 1994 | Jun 1994 | 10 | 9.7% | +66.4% | +12035.8% |
| Jun 1994 | Jul 1994 | 2 | 12.7% | +68.1% | +13249.4% |
| Jun 2006 | Jul 2006 | 3 | 1.6% | +50.4% | +872.7% |
| Oct 2008 | Jan 2010 | 65 | 42.4% | -10.1% | +694.6% |
| Jan 2010 | Mar 2010 | 5 | 5.1% | +11.5% | +670.6% |
| May 2010 | Jan 2011 | 35 | 19.3% | +11.7% | +637.4% |
| Aug 2011 | Jan 2012 | 22 | 16.6% | +7.1% | +685.3% |
| Mar 2020 | Apr 2020 | 3 | 12.5% | +67.1% | +150.4% |
| Jun 2022 | Jul 2022 | 6 | 9.2% | +53.6% | +75.4% |
| Aug 2022 | Sep 2022 | 2 | 5.5% | +35.9% | +63.9% |
| Sep 2022 | Oct 2022 | 4 | 6.2% | +39.5% | +64.0% |
| Oct 2022 | Nov 2022 | 1 | 3.0% | +32.4% | +60.3% |
| Apr 2026 | Jun 2026 | 8 | 9.8% | N/A | +10.8% |
| Jul 2026 | Jul 2026 | 1 | 0.4% | N/A | +1.8% |
| Average | 8 | — | +41.8% | — |
Frequently Asked Questions
Is SYK below its 200-week moving average?
No. Stryker Corporation (SYK) is currently 1.0% above its 200-week moving average of $322.54. It would need to fall to $322.54 to cross below the line.
What is SYK's 200-week moving average price?
Stryker Corporation's 200-week moving average is $322.54 as of 2026-07-31. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when SYK drops below its 200-week moving average?
SYK has crossed below its 200-week moving average 23 times in our data. On average, buying at that moment produced a one-year return of +41.8%. These dips have historically been decent entry points. These episodes lasted 8 weeks on average.
Is SYK a good value right now?
Here's what our data says about SYK as of 2026-07-31: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 50. Free cash flow yield is 4.1%. Return on equity is 16.5%. Price-to-book is 5.4x. This is not a buy or sell recommendation — always do your own research.
How does SYK compare to the S&P 500?
Over the past 33.6 years, $100 invested in SYK would have grown to $9276, compared to $3098 for the S&P 500. That's 14.4% annualized vs 10.8% for the index. SYK has outperformed the broader market over this period.
Does SYK pay a dividend?
Yes. Stryker Corporation currently pays a dividend yield of 108.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-07-31